Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc. et al
Case Number:
1:10-cv-00892
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 22, 2012
Judge Bars Mylan's Oracea Generic In Galderma IP Case
A Delaware federal judge on Friday barred Mylan Pharmaceuticals Inc. from selling a generic version of Galderma Laboratories Inc.'s rosacea drug Oracea, even though the patent Mylan was found to have infringed was issued after its generic received government approval.
-
August 26, 2011
Mylan's Generic Oracea Infringes Galderma IP: Judge
A Delaware federal judge on Friday found that Mylan Pharmaceuticals Inc.'s efforts to bring a generic version of the rosacea drug Oracea to the market infringed a valid patent held by Galderma Laboratories Inc.